MONOCLONAL ANTIBODY DIRECTED AGAINST THE P17 PROTEIN OF HIV, CAPABLE OF NEUTRALISING THE BINDING OF P17 TO THE P17 RECEPTOR (P17R)

摘要

Anti-HIV p17 monoclonal antibodies are described, which are capable of neutralizing the binding between multiple HIV-1 p17 protein variants and the p17R receptor are provided. Pharmaceutical compositions and methods of treatment utilizing these antibodies are also provided.